Navigation Links
MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:3/4/2008

o, statements about the Company's product development and commercialization schedule, including, particularly, future plans with respect to its Amoxicillin PULSYS products; any statements regarding Dr. Rudnic's comments and expectations concerning the Company; the Company's initiatives to develop improved antibiotics; the Company's existing and anticipated collaborative agreements; and any financial forecasts and projections for 2008 and thereafter included under the Financial Guidance section of this announcement.

The actual results realized by MiddleBrook could differ materially from these forward-looking statements, depending in particular upon the risks and uncertainties described in the Company's filings with the Securities and Exchange Commission. These include, without limitation, risks and uncertainties relating to the Company's financial results and the ability of the Company to (1) raise additional capital and continue as a going concern, (2) maintain its Keflex 750 sales, (3) retain marketing approval for its MOXATAG product, (4) successfully reduce costs, (5) reach profitability, (6) prove that the preliminary findings for its product candidates are valid, (7) receive required regulatory approvals, (8) successfully conduct clinical trials in a timely manner, (9) establish its competitive position for its products, (10) develop and commercialize products that are superior to existing or newly developed competitor products, (11) develop products without any defects, (12) have sufficient capital resources to fund its operations, (13) protect its intellectual property rights and patents, (14) implement its sales and marketing strategy, (15) successfully attract and retain collaborative partners, (16) successfully commercialize and gain market acceptance for its Keflex products, (17) successfully obtain sufficient manufactured quantities of its drug products at acceptable rates, and (18) retain its senior management and other personnel. Existing and pr
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment g...ns the only one to show consistent growth during t...hospitals remain in trouble, and health systems ar...personnel, instead of just administrators. , ...ealth care employment continued growing in October...
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/...companyfocusedondevelopingandcommercializingnovelp...Tonno,PresidentandChiefExecutiveOfficer,isschedule...ference,tobeheldDecember1-2,2009atTheNewYorkPalace...Ghiglieri,ChiefFinancialOfficer,willbeavailabletor...
(Date:11/24/2009)... The FBI recently approved ...ratories participating in or generating DNA record... Madison, WI USA (PRWEB) -- The FBI r... System for use by laboratories participating in,...ndex System (NDIS). NDIS currently contains more t...
(Date:11/24/2009)...,, DUBLIN,November24/PRNewswire-FirstCall/--Shi...iopharmaceuticalcompany,today,announcedthatithassu...cerasealfa,thecompany,senzymereplacementtherapyind...isisthethirdmarketing,applicationforvelaglucerasea...theUnitedStatesandCanada. , Basedonaglobalsup...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...ogy is soliciting proposals from all technology ar...ed Technology Program competition. Last year comp... awarded to UW-Madison spin-off companies. , ,A pu... Chicago, Ill at which the program will be discuss...partnership aids companies in accelerating the dev...
...on the effects of outsourcing technology and offsh...ight on the issue. Whatever the product, there is ...bor. The effects of this are hurting many aspects ...snt matter what you are making, whether you manufa...ogy support call centers, write code or create the...
...n Eau Claire Thursday, Gov. Doyle announced TTM T...00 in Technology Zone tax credits. The award will ...jobs at its Chippewa Falls facility and invest $8....ies produces complex printed computer circuit boar...gest, its Chippewa Falls plant, responsible for ov...
Other Biology Technology:Offshore outsourcing affects American workers 2Offshore outsourcing affects American workers 3
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research ...ic river ecosystems reveals predictable temporal p...e communities as markers for monitoring climate ch...is week in the Proceedings of the National Academ... communities in the six rivers shifted synchronous...
(Date:11/23/2009)..., Cambridge, Mass. November 23, 2009 Applied ...ntain lily ( Hosta lancifolia ), a characteristic ...osely packed ripples along the edges. The simple c...n resulting from bending during differential growt..., stretching foam ribbons. , Haiyi Liang, a post...
(Date:11/23/2009)... Farmington, CT Current research suggests that a ...sease. The related report by Nichols et al, "Uniq...a New Class of TLR2 Ligands Capable of Enhancing A...f The American Journal of Pathology . , Multipl...m attacks the brain and spinal cord, affects nearl...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Factors from common human bacteria may trigger multiple sclerosis 2Heat Sinks Market to Reach 242 64 Billion by 2015 According to New Report by Global Industry Analysts Inc 49703 1Heat Sinks Market to Reach 242 64 Billion by 2015 According to New Report by Global Industry Analysts Inc 49703 2Heat Sinks Market to Reach 242 64 Billion by 2015 According to New Report by Global Industry Analysts Inc 49703 3BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 1BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 2BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 3BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 4A urine test for appendicitis 3F 8958 1A urine test for appendicitis 3F 8958 2A urine test for appendicitis 3F 8958 3
...esentatives from the Midlands Consortium say they ...at the group has been chosen to host a new 1billio..., The Midlands Consortium is comprised of the uni...am three world-class partners, all with extensive...ies. Generous financial support has been provided...
Minister Lunn to attend Union of BC Municipalities Pine Beetle Conference
... a career devoted to understanding how best to man...enstiel School faculty member Dr. Jerry Ault has p...f Sustainable Fisheries: Biology and Management of... an assistant professor in the Division of Marine ... census, has a unique high-tech tagging approach t...
Other Biology News:Midlands Consortium delighted to be chosen to host £1 billion energy institute 2Midlands Consortium delighted to be chosen to host £1 billion energy institute 3New tarpon, bonefish compendium published 2
Mouse Anti-Human LAT, phospho (Tyr226) Monoclonal Antibody, Unconjugated, Clone J96-1238.58.93 from BD Biosciences Pharmingen
L-Selenomethionine from Calbiochem
Xylene Resistant (X/R) Red System, 1000 Tests (SIGNET) from Covance Research Products, Inc
Anti-YAP, phospho (Ser127) Antibody, Unconjugated from Cell Signaling Technology
Biology Products: